Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study.

[1]  Jens Overgaard,et al.  Tumor hypoxia is independent of hemoglobin and prognostic for loco-regional tumor control after primary radiotherapy in advanced head and neck cancer , 2004, Acta oncologica.

[2]  James B. Mitchell,et al.  Proceedings of the Oxygen Homeostasis/Hypoxia Meeting. , 2004, Cancer research.

[3]  G. Semenza Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.

[4]  J. Alsner,et al.  475 The prognostic value of serum osteopontin, HIF-1 alpha and pO2 measurements in advanced head and neck tumors treated by radiotherapy , 2003 .

[5]  Johan Bussink,et al.  Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  Andreas Dietz,et al.  Predictive Value of the Tumor Oxygenation by Means of pO2 Histography in Patients with Advanced Head and Neck Cancer , 2001, Strahlentherapie und Onkologie.

[7]  A Dietz,et al.  Repeatability and prognostic impact of the pretreatment pO(2) histography in patients with advanced head and neck cancer. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  J. Overgaard,et al.  A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  Kumar Impact of Anemia in Patients With Head and Neck Cancer. , 2000, The oncologist.

[10]  D J Terris,et al.  Head and Neck Cancer: The Importance of Oxygen , 2000, The Laryngoscope.

[11]  H. Feldmann,et al.  Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas. , 2000, International journal of radiation oncology, biology, physics.

[12]  M. Dewhirst,et al.  Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  M Molls,et al.  Influence of the hypoxic subvolume on the survival of patients with head and neck cancer. , 1999, International journal of radiation oncology, biology, physics.

[14]  D A Bloch,et al.  Tissue oxygen distribution in head and neck cancer patients , 1999, Head & neck.

[15]  C Weigel,et al.  Oxygenation of squamous cell carcinoma of the head and neck: comparison of primary tumors, neck node metastases, and normal tissue. , 1998, International journal of radiation oncology, biology, physics.

[16]  L. Bastholt,et al.  A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  M. Dewhirst,et al.  Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. , 1997, International journal of radiation oncology, biology, physics.

[18]  P. Lambin,et al.  Oxygenation of head and neck tumors , 1993, Cancer.

[19]  P Vaupel,et al.  Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. , 1991, Cancer research.

[20]  R. Durand Keynote address: the influence of microenvironmental factors on the activity of radiation and drugs. , 1991, International journal of radiation oncology, biology, physics.

[21]  C. Grau,et al.  Cytotoxic effect of misonidazole and cyclophosphamide on aerobic and hypoxic cells in a C3H mammary carcinoma in vivo. , 1990, British Journal of Cancer.

[22]  P. Okunieff,et al.  Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. , 1989, Cancer research.

[23]  R. Gatenby,et al.  Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. , 1988, International journal of radiation oncology, biology, physics.

[24]  J. Overgaard,et al.  Primary radiotherapy of larynx and pharynx carcinoma--an analysis of some factors influencing local control and survival. , 1986, International journal of radiation oncology, biology, physics.

[25]  H. Kaplan,et al.  On the relative importance of hypoxic cells for the radiotherapy of human tumours. , 1974, European journal of cancer.

[26]  L. H. Gray,et al.  The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. , 1953, The British journal of radiology.

[27]  Quynh-Thu Le,et al.  Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[28]  Adrian L. Harris,et al.  Hypoxia — a key regulatory factor in tumour growth , 2002, Nature Reviews Cancer.

[29]  C. Aquino-Parsons,et al.  Measuring hypoxia in solid tumours--is there a gold standard? , 2001, Acta oncologica.

[30]  J. Overgaard,et al.  Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[31]  S M Bentzen,et al.  Measurement of human tumour oxygenation status by a polarographic needle electrode. An analysis of inter- and intratumour heterogeneity. , 1994, Acta oncologica.